Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 82

1.

Thrombocytopenia after tetanus prophylaxis with tetanus-diphtheria (Td) vaccine.

Serinken M, Gozlukaya A, Sari I, Karcioglu O.

J Emerg Med. 2013 Feb;44(2):e287-8. doi: 10.1016/j.jemermed.2012.05.039. Epub 2012 Nov 8. No abstract available.

PMID:
23141562
2.

Thrombocytopenia after tetanus vaccination.

Mortelmans LJ, Gert C, Guido JY.

Eur J Emerg Med. 2009 Dec;16(6):345-6. doi: 10.1097/MEJ.0b013e328321b7a4. No abstract available.

PMID:
19904082
3.

Immunogenicity and safety of diphtheria-tetanus vaccine in adults.

Choi JH, Choo EJ, Huh A, Choi SM, Eom JS, Lee JS, Park SH, Kang JH.

J Korean Med Sci. 2010 Dec;25(12):1727-32. doi: 10.3346/jkms.2010.25.12.1727. Epub 2010 Nov 24.

4.

Adverse event reporting rates following tetanus-diphtheria and tetanus toxoid vaccinations: data from the Vaccine Adverse Event Reporting System (VAERS), 1991-1997.

Lloyd JC, Haber P, Mootrey GT, Braun MM, Rhodes PH, Chen RT; VAERS Working Group.

Vaccine. 2003 Sep 8;21(25-26):3746-50.

PMID:
12922107
5.

Psoriasis triggered by tetanus-diphtheria vaccination.

Macias VC, Cunha D.

Cutan Ocul Toxicol. 2013 Jun;32(2):164-5. doi: 10.3109/15569527.2012.727936. Epub 2012 Oct 10.

PMID:
23050604
7.

Immunogenicity and reactogenicity of the adult tetanus-diphtheria vaccine. How many doses are necessary?

Bayas JM, Vilella A, Bertran MJ, Vidal J, Batalla J, Asenjo MA, Salleras LL.

Epidemiol Infect. 2001 Dec;127(3):451-60.

8.

A randomized trial of two acellular pertussis vaccines (dTpa and pa) and a licensed diphtheria-tetanus vaccine (Td) in adults.

Turnbull FM, Heath TC, Jalaludin BB, Burgess MA, Ramalho AC.

Vaccine. 2000 Nov 8;19(6):628-36.

PMID:
11090714
9.

Frequency of medically attended adverse events following tetanus and diphtheria toxoid vaccine in adolescents and young adults: a Vaccine Safety Datalink study.

Jackson LA, Yu O, Belongia EA, Hambidge SJ, Nelson J, Baxter R, Naleway A, Gay C, Nordin J, Baggs J, Iskander J.

BMC Infect Dis. 2009 Oct 5;9:165. doi: 10.1186/1471-2334-9-165.

10.

Immunogenicity and safety of diphtheria-tetanus vaccine in pre-adolescent and adolescent South Koreans.

Lee SY, Kwak GY, Nam CH, Kim JH, Hur JK, Lee KY, Park JS, Kim HM, Kang JH.

Vaccine. 2009 May 21;27(24):3209-12. doi: 10.1016/j.vaccine.2009.03.037. Epub 2009 Apr 7.

PMID:
19446193
11.
12.

Immunogenicity and safety of a single intramuscular dose of a diphtheria-tetanus toxoid (Td) vaccine (GC1107) in Korean adults.

Lee S, Park WB, Shin KH, Ahn DH, Yoon SH, Cho JY, Shin SG, Jang IJ, Yu KS.

Vaccine. 2011 Oct 13;29(44):7638-43. doi: 10.1016/j.vaccine.2011.08.003. Epub 2011 Aug 22.

PMID:
21864613
13.

Safety and immunogenicity of single dose of tetanus-diphtheria (Td) vaccine among non/partially immune children against diphtheria and/or tetanus, Hyderabad, India, 2007.

Bitragunta S, Murhekar MV, Chakravarti A, Verma V, Namjoshi GS, Parekh SS, Sharma HJ, Kumar BK, Gupte MD.

Vaccine. 2010 Aug 23;28(37):5934-8. doi: 10.1016/j.vaccine.2010.06.047. Epub 2010 Jul 8.

PMID:
20620169
14.

Reactogenicity of meningococcal C conjugate vaccines when administered at the same time as, or a month prior to or after, tetanus and diphtheria booster vaccinations.

Southern J, Gelb D, Andrews N, Waight PA, Morris R, Cartwright K, Miller E.

Hum Vaccin. 2006 Nov-Dec;2(6):237-42. Epub 2006 Nov 11.

PMID:
17102644
15.

How soon after a prior tetanus-diphtheria vaccination can one give adult formulation tetanus-diphtheria-acellular pertussis vaccine?

Halperin SA, Sweet L, Baxendale D, Neatby A, Rykers P, Smith B, Zelman M, Maus D, Lavigne P, Decker MD.

Pediatr Infect Dis J. 2006 Mar;25(3):195-200.

PMID:
16511379
16.

Reactogenicity profile of tetanus-diphtheria (adult-type) vaccine: results of a naturalistic study performed at an adult vaccination center.

Vilella A, Dal-Ré R, Simó D, García-Corbeira P, Diego P, Bayas JM.

J Clin Pharmacol. 2000 Nov;40(11):1267-73.

PMID:
11075312
17.

[Immunization of patients with chronic obstructive pulmonary disease with vaccines of Bubo-M and hepatitis B].

Kulakova NA, Kostinov MP, Magarshak OO, Borisova VN, Polishchuk VB.

Zh Mikrobiol Epidemiol Immunobiol. 2010 Jul-Aug;(4):27-31. Russian.

PMID:
20795382
18.

Tetanus-diphtheria booster in non-responding tetanus-diphtheria vaccinees.

Van der Wielen M, Van Damme P.

Vaccine. 2000 Dec 8;19(9-10):1005-6. No abstract available.

PMID:
11203498
19.

Relapse of Wells' syndrome in a child after tetanus-diphtheria immunization.

Calvert J, Shors AR, Hornung RL, Poorsattar SP, Sidbury R.

J Am Acad Dermatol. 2006 May;54(5 Suppl):S232-3. No abstract available.

PMID:
16631949
20.

Spontaneous resolution of diphtheria-tetanus vaccine hypersensitivity in a pediatric population.

Bégin P, Vu MQ, Picard M, Paradis L, Des Roches A.

Allergy. 2011 Nov;66(11):1508-10. doi: 10.1111/j.1398-9995.2011.02698.x. Epub 2011 Sep 2. No abstract available.

Supplemental Content

Support Center